TCL Archive In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set October 28, 1977
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
